Rosuva^® EZ

Indication:
• Primary Hyperlipidemia
• Homozygous Familial Hypercholesterolemia

Dosage & Administration:
The dosage range of Rosuva^® EZ is 5/10 mg to 40/10 mg orally once a day. The recommended dosage depends on the indication for usage, LDLC, and individual risk for cardiovascular events.
Patients with severe renal impairment (not on hemodialysis): initiate at 5 mg/10mg once daily; do not exceed 10 mg/10 mg once daily.
Patients should swallow Rosuva^® EZ tablet whole. Tablets should not be crushed, dissolved, or chewed.
Administer Rosuva^® EZ at least 2 hours before or 4 hours after administration of a bile acid sequestrant.
Administer Rosuva^® EZ at least 2 hours before administration of an aluminum and magnesium hydroxide combination antacid.

Preparation:
Rosuva^® EZ 5/10: Each box contains 30 tablets in Alu-Alu blister pack.
Rosuva^® EZ 10/10: Each box contains 30 tablets in Alu-Alu blister pack.
Rosuva^® EZ 20/10: Each box contains 20 tablets in Alu-Alu blister pack.